Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romidepsin in Metastatic or Unresectable Soft Tissue Sarcomas
NCT00112463Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jan 2005
- Primary completion
- Oct 2008
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of romidepsin in soft tissue sarcoma (STS), sponsored by National Cancer Institute. Started Jan 2005; status: completed.
02
Drugs
romidepsin
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00112463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00112463.